Four contract packaging and repackaging companies in the pharmaceutical industry have joined forces to create a new, single-source service provider, Aphena Pharma Solutions (www.aphenapharma.com).
Aphena is a new corporation based on a strategic alliance among Celeste Contract Packaging, PrePak Systems, TestPak, and Integrated Pharmaceutical Packaging.
A+ Secure Packaging LLC reports that Louis Weiner has joined the custom contract packager as vice president of sales and a LLC Member. Formerly an account director at Catalent Pharma Solutions, Weiner brings 27 years of experience in various roles in contract pharmaceutical packaging including engineering, operations and sales. He will be responsible for sales and marketing efforts at A+ Secure Packaging, which serves manufacturers of pharmaceutical, nutraceutical, and OTC products as well as medical devices.
Accuristix has acquired Nova Pack Ltd., a contract packaging, repackaging, and assembly provider for over-the-counter (OTC), health and beauty, healthcare, and pharmaceutical products. Accuristix is a third-party logistics company currently operating four distribution centers in the Toronto Area, with others in Vancouver and Los Angeles. The acquisition allows both companies to offer a broader scope of services to the Canadian healthcare marketplace.
PrePak Holdings Inc. (Cookeville, TN) has acquired TestPak (Whippany, NJ), a contract packaging company active in the pharmaceutical, nutritional, and consumer products markets. PrePak Holdings, a group of companies focused on contract manufacturing and packaging, completed the acquisition on August 31.
PrePak Holdings Inc. announces that it has named Renard Jackson to serve as the company’s new chief executive officer and president. PrePak serves mid- to large-sized companies in the pharmaceutical, nutritional, consumer product, medical device, and animal health markets. With FDA-registered and cGMP compliant facilities, PrePak subsidiaries include PrePak Systems, Celeste Contract Manufacturing and Packaging, and Integrated Pharmaceutical Packaging.
Comar Inc. (Buena, NJ) announced that on Fri., April 16, 2010 it finalized a transaction acquiring 100% of Universal Container Corp.'s (Unicon) assets from its current shareholders. Based in Cayey, Puerto Rico, Unicon is a leading manufacturer of high quality injection molded, injection blow molded, and extrusion blow molded parts and containers. Comar, based in Buena, New Jersey, is a manufacturer of proprietary pharmaceutical packaging with a leadership position in the Liquid Medication Delivery Device Market. The transaction closed on April 16, 2010 and the terms were not disclosed.
Contract packagers are often providing a host of value-added services through extended partnering arrangements with their pharmaceutical customers.
The Healthcare Distribution Management Association (HDMA) presented its first Distribution Management Award to AmerisourceBergen Packaging Group (ABPG) and Pfizer Pharmaceuticals for its Toviaz Physician Sample Package Optimization project. The package was a redesigned format that enabled Pfizer to deliver the samples efficiently and to encourage patient compliance.
According to a new technical market research report from BCC Research (Wellesley, MA), the global market for contract pharmaceuticals is worth an estimated $177 billion in 2009, and is expected to increase to $299 billion in 2014, for a 5-year compound annual growth rate of 11.1%. The report, entitled “Contract Pharmaceuticals Manufacturing, Research, and Packaging,” examines the different types of contracting companies in the pharmaceuticals industry.
Vetter is developing a new 24,000-sq-ft facility at the Illinois Science + Technology Park in Skokie, IL, to support biopharmaceutical companies interesed in accelerating development and controling costs. Vetter, a contract manufacturer, produces high-quality, aseptically prefilled injection systems including syringes, vials, and injection pens. The company mainly fills and finishes complex compounds indicated for conditions such as cancer, Parkinson’s disease, and inflammatory and autoimmune disorders.